Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 17389597
Uemura K, et al. (2007) GSK3beta activity modifies the localization and function of presenilin 1. J Biol Chem 282, 15823-32 17389597
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S353-p - PSEN1 (human)
Modsite: sHLGPHRstPEsRAA SwissProt Entrez-Gene
Orthologous residues
PSEN1 (human): S353‑p, PSEN1 iso2 (human): S349‑p, PSEN1 iso3 (human): , PSEN1 (mouse): S353‑p, PSEN1 (rat): S354‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Relevant cell lines - cell types - tissues:  293 (epithelial)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE GSK3B (human) transfection of constitutively active enzyme
Downstream Regulation
Effect of modification (function):  intracellular localization, molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
CDH2 (human) Disrupts co-immunoprecipitation
CTNNB1 (human) Disrupts co-immunoprecipitation
Comments:  reduced interaction was observed in the constitutively active GSK3beta (S9A) mutant; GSK3beta activation downregulates PI3K/Akt signaling probably by reducing the interaction of PSEN1 with N-cadherin (CDH2)/ beta catenin (CTNNB1);

S357-p - PSEN1 (human)
Modsite: PHRstPEsRAAVQEL SwissProt Entrez-Gene
Orthologous residues
PSEN1 (human): S357‑p, PSEN1 iso2 (human): S353‑p, PSEN1 iso3 (human): , PSEN1 (mouse): S357‑p, PSEN1 (rat): S358‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Relevant cell lines - cell types - tissues:  293 (epithelial)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE GSK3B (human) transfection of constitutively active enzyme
Downstream Regulation
Effect of modification (function):  intracellular localization, molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
CDH2 (human) Disrupts co-immunoprecipitation
CTNNB1 (human) Disrupts co-immunoprecipitation
Comments:  reduced interaction was observed in the constitutively active GSK3beta (S9A) mutant; GSK3beta activation downregulates PI3K/Akt signaling probably by reducing the interaction of PSEN1 with N-cadherin (CDH2)/ beta catenin (CTNNB1);